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PENYIASATAN AKTIVITI PENCHEGAHANKEMO DENGAN 
MENGGUNAKAN DUA VARIETI AIR KELAPA YANG DISEJUK-
KERINGKAN KE ATAS TITISAN SEL KANSER SERVIK 
 
ABSTRAK 
 
Air kelapa dianggap sebagai penawar semulajadi untuk manusia. Bukan sahaja sebagai 
minuman yang menyegarkan untuk menghilangkan dahaga, air kelapa digunakan sejak dari 
bayi ke alam dewasa sebagai tonik kesihatan terutamanya oleh orang-orang di kawasan 
tropika. Dengan peningkatan penyakit kanser, terapi antikanser baru seperti pendekatan 
pencegahan-kemo diperlukan dengan kadar segera. Dalam kajian ini, didapati bahawa air 
kelapa menunjukkan aktiviti perencatan pertumbuhan terhadap sel HeLa dengan nilai IC50 
100 μg/ml bagi kedua-dua varieti air kelapa MATAG dan air kelapa Rendah Aromatik yang 
telah disejuk-keringkan. Selepas 72 jam rawatan, pemerhatian menggunakan mikroskop 
menunjukkan perubahan morfologi apoptotik dalam sel HeLa yang dirawat menggunakan air 
kelapa MATAG yang telah disejuk-keringkan. Sementara itu, ciri-ciri apoptosis dan autofagi 
dapat diperhatikan dalam sel HeLa yang dirawat meggunakan air kelapa Rendah Aromatik 
yang telah disejuk-keringkan. Sebaliknya, pemerhatian di bawah mikroskop pendarfluor 
menunjukkan intens kromatin yang tinggi dan morfologi apoptotic terdapat di dalam kedua-
dua jenis rawatan terhadap sel HeLa yang telah  diwarnakan dengan pewarna Hoechst. 
Untuk menilai aktiviti anti-proliferatif dalam tempoh rawatan yang berpanjangan, sel HeLa 
dirawat dengan air kelapa MATAG dan air Kelapa Rendah Aromatik yang telah disejuk-
keringkan selama lapan hari tempoh pembiakan. Hasil kajian menunjukkan bahawa air 
kelapa MATAG yang telah disejuk-keringkan mampu untuk terus merencat percambahan sel 
HeLa sehingga hari terakhir rawatan. Sebaliknya, kesan perencatan air kelapa Rendah 
Aromatik yang telah disejuk-keringkan adalah tidak stabil dalam tempoh masa yang lama, 
oleh itu kesan perencatan berkurangkan. Dengan itu, hasil kajian menunjukkan bahawa air 
kelapa MATAG yang telah disejuk-keringkan mempunyai kesan anti-proliferatif lebih baik 
berbanding dengan air kelapa Rendah Aromatik yang telah disejuk-keringkan. 
Kesimpulannya, kedua-dua jenis air kelapa yang telah disejuk-keringkan menunjukkan 
aktiviti penchegahankemo yang positif seterusnya dianggap sebagai terapi antikanser yang 
berpotensi. 
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INVESTIGATION OF CHEMOPREVENTIVE ACTIVITY WITH TWO 
DIFFERENT VARIETIES OF FREEZE DRIED COCONUT WATER 
(FDCW) ON CERVICAL CANCER CELL LINE 
 
ABSTRACT 
 
Coconut water is considered as nature’s elixir to mankind. Not only as a refreshing beverage 
to quench the thirst, coconut water is consumed starting from infancy to adulthood as a 
health tonic especially by people of the tropics. With increasing trend of cancer prevalence, 
novel anticancer therapies such as chemoprevention approach urgently needed. In this study, 
it was found that coconut water exert its anti-proliferative activity against HeLa cells with 
IC50 value of 100 µg/ml in both MATAG FDCW and Aromatic Dwarf (AD) FDCW 
varieties. After 72 hours of treatment, observation under inverted microscope showed typical 
apoptotic morphological alteration in HeLa cells exposed with MATAG FDCW. Meanwhile, 
features of apoptosis and autophagy observed in HeLa cells treated with AD FDCW. 
Observation under fluorescence microscope showed chromatin condensed and apoptotic 
bodies in both treatments against stained HeLa cells with Hoechst dye. To evaluate the anti-
proliferative activity with prolong treatment exposure, treated HeLa cells with respective 
treatments were subjected to eight days of incubation period. Results showed that MATAG 
FDCW was able to continuously suppressed HeLa cells proliferation until final day of 
treatment. However, AD FDCW effect was instable with prolonged time hence, the 
suppression effect was reduced. Thus, the results suggested that MATAG FDCW exerts 
better anti-proliferative effect compared to AD FDCW. In conclusion, both FDCW varieties 
demonstrated positive chemopreventive activity thence considered as potential novel 
anticancer therapies.   
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CHAPTER 1 
INTRODUCTION 
 
1.1 Background of the study 
Cancer is claimed to be one of the most leading causes of death worldwide. Out of three 
people, one person is diagnosed with cancer (Rang HP, 2007). In 2008 it was reported that 
about 12.7 million people were diagnosed with cancer and 7.6 million people lost their lives 
to cancer annually. By 2030, cancer is predicted to ascend over 20 million (Jemal et al., 
2011) ; (Rang HP, 2007). According to National Cancer Registry Report, it was reported in 
2007 that the common cause of death in hospitals after heart diseases and septicemia was 
cancer. New cancer morbidity was diagnosed with the total of 18, 219 cases in 2007 
whereby, it comprises of 44.6% males and 55.4% females (Omar and Tamin, 2011).  
 Cervical cancer is primarily a preventable disease, yet it remains the third most 
common cancer in women worldwide with estimated new cases up to 529, 800 (Jemal et al., 
2011). Likewise, in Malaysia cervical cancer ranked in the third position which accounts 847 
cases of total most frequent cancers among females (Omar and Tamin, 2011). Nevertheless, 
cervical cancer morbidity and mortality have been reduced through screening and treatment 
in earlier stages (Teoh et al., 2015). Even so, modern conventional therapies are ineffective 
since the overall cancer burden is still high. Hence, this has created an imperative need for 
novel intervention (Neergheen et al., 2010). 
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 With this concern, numerous researches have been done to develop new therapeutic 
strategies in combating this terrifying disease. Chemoprevention is among the active area of 
investigation with enormous potential. As was first introduced by Sporn in 1976, 
chemoprevention is an attempt to prevent, reverse, or suppress carcinogenic progression by 
the use of natural, biological, chemical, or synthetic agents. This approach tackles 
carcinogenesis from the initial phases until the progression states (Sporn, 1976); (Sporn and 
Suh, 2000); (Tsao et al., 2004).  
Natural phytochemicals or dietary supplements have gained an upsurge of interest in 
the field of cancer prevention and therapy. Traditional herbs, folk medicine, or functional 
food have been long used by Asians since thousand years ago to prevent or treat ailments in 
the prior of the introduction of Western Medicine. At present, numbers of scientific data 
have been collected which emphasized the interrelationship of lifestyle-related diseases like 
cancer, heart disease, diabetes, etc. It is believed that right diet modification in daily food 
intake can prevent such chronic diseases (Iqbal Ahmad, 2006).  
Through research, dietary phytochemicals which can be found in vegetables, spices, 
fruits, and beverages have exhibited potential anticancer properties. Their anti-cancer 
activities can be learned through multiple pathways and mechanisms. Dietary 
phytochemicals play multiple roles in the normal biological processes and also involved in 
the regulation of pathological progressions. Moreover, dietary phytochemicals generally 
have low toxicity level, hence making these bioactive natural compounds as an essential 
cancer chemopreventatives agents (Shankar et al., 2013); (Shukla et al., 2014). 
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 Malaysia is a tropical country endowed with vast natural resources. The favorable 
climate and soil conditions present this country with rich biological diversity hence, 
renowned as one of the world’s twelve megadiversity countries (Hezri and Nordin Hasan, 
2006). Nevertheless, the scientific data regarding our nation’s natural resources are lacking 
and yet to be investigated (Hezri and Nordin Hasan, 2006). For that, this study is carried out 
as an effort to document the scientific evidence about one of the nation natural resources, 
specifically coconut water. The purpose of this study is to investigate the cancer 
chemoprevention activity with two different varieties of coconut water on cervical cancer 
cell line. 
Coconut water has been used especially in the tropical countries not only as a 
refreshing beverage but it is also considered as health tonic. The Hawaiians refer coconut 
water as “the dew from the heavens” due to its enormous benefits. The folks believed that 
coconut water is useful in the treatments for poisoning, dehydration, heatstroke, boils, 
fatigue, urinary tract infections, kidney stones, constipation, digestive disturbances, diarrhea, 
malnutrition, osteoporosis, and sterility (Prades et al., 2012); (Fife, 2008). With vast benefits 
of coconut water, it is believed that this health beverage will exhibit positive 
chemoprevention activity on cancer cells. In this study, the chemoprevention activity of 
coconut water from two different varieties, MATAG and Aromatic Dwarf, were determined 
by their ability to suppress or inhibit the growth of cervical cancer cells. 
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1.2 HYPOTHESIS 
The hypothesis of this study is that the different varieties of freeze dried coconut water will 
exhibit different types of chemoprevention activity with regards of inhibitory concentration 
dose and cell proliferation.  
 
1.3 OBJECTIVES 
1. To determine the inhibitory concentration with two different varieties of freeze 
dried coconut water on cervical cancer cell line. 
2. To observe any morphological changes after treatment with two different 
varieties of freeze dried coconut water on cervical cancer cell line. 
3.  To identify the anti-proliferative effects with two different varieties of freeze 
dried coconut water on cervical cancer cell line. 
 
 
 
 
 
 
 
 
The experimental design flowchart of this study is shown in APPENDIX A. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Cancer  
Generally, cancer is linked to death since it is incurable and even the etiology is not fully 
understood. Thence, cancer has become a terrifying illness and it is in the center of attention 
in medical field (King and Robins, 2006). Regardless the declaration of “war on cancer” by 
US government in 1971, the morbidity of cancer cases in the recent years have decreased not 
more than 1% and the mortality only reduced not more than 2% (Barbara et al., 2014) ; 
(Siegel et al., 2012). To add, the prevalence of cancer burden and incidence was reported as 
the highest in economically developing countries, which include Malaysia. Moreover, the 
survival also tend to be poorer in developing countries (Bray et al., 2012).  
The term cancer, malignant or benign neoplasm marked by uncontrolled 
multiplication of abnormal cells. The pathogenesis of cancer manifest to varying levels and 
classified by four characteristics that distinguish them from normal cells. Features of cancer 
cells include uncontrolled proliferation, dedifferentiation and loss of function, invasiveness, 
and aptitude to spread or metastasize to other parts of the body (Rang HP, 2007).  Due to 
mutation, a normal cell turns into a cancerous cell either by inherited or acquired. It is truly a 
complex process of progressing genetic modification in human somatic cells and often with 
no fixed molecular basis. Although the genetic predisposition factors or infectious pathogens 
can markedly increase the risk of cancer, neither of those alone is necessary and sufficient to 
cause malignancy (Barbara et al., 2014).  
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Carcinogenesis defined as the process whereby benign epithelial cells acquire 
attributes of neoplastic malignancy. Deregulation of sound orchestrated process cause the 
normal cells to turn into malignant cells. The pathogenesis of cancer metastasis comprises of 
selective, sequential, and interlinked steps. Aftermath of the metastatic process depends on 
both intrinsic properties of the tumor cells and their interaction with host factors (Langley 
and Fidler, 2007). Figure 2.1 shows the pathogenesis of cancer metastasis. 
Cancer carcinogenesis is a multistage process that includes the initiation phase, 
promotion phase, and progression phase (Khambete and Kumar, 2014). The initiation phase 
is due to carcinogenic insult, in which it involves with environmental exposure such as toxic 
chemicals or radiations. Following the insult, cells will undergo promotion phase whereby 
the initiated cells turn to non-malignant tumor cells (adenoma) (Kasdagly et al., 2014). Later 
on in the progression phase, cells transformed to neoplastic malignant cells which are 
irreversible and they acquire the ability to invade and metastasis. Therefore, cancer is not 
merely to be removed or killed, but it is a course to be prevented, managed and controlled 
(Barbara et al., 2014). 
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Figure 2.1: Pathogenesis of Cancer Metastasis. 
(Adapted from Langley and Fidler, 2007) 
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2.1.1 Hallmarks of cancer 
Cancer is widely specified as a group of diseases with common hallmarks of uncontrolled 
growth and life-threatening (King and Robins, 2006). To understand the diversity of 
neoplastic disease, Hanahan and Weinberg (2000) had proposed six hallmarks of cancer 
establishing an organizing principle that provides a coherent framework. These hallmarks 
concept discussed on the notion that a normal cell change progressively to a neoplastic state. 
It also emphasized that the normal cells acquire the attributes that facilitate them to become 
tumorigenic and ultimately malignant (Hanahan and Weinberg, 2011).  Figure 2.2 depicts 
the proposed hallmarks. 
The first hallmark, which is the vital trait of cancer capabilities, is the ability to 
sustain the proliferative signaling. This growth-promoting signal continuously being released 
and regulates progression through cell cycle as well as cell growth hence, becomes 
immortalized (Hanahan and Weinberg, 2011). The second hallmark of cancer cells is that 
they were able to evade growth suppressors by circumvent tumor suppressor genes actions. 
For instance, prototypical tumor suppressors that encode TP53 and RB (retinoblastoma-
associated) proteins govern the decision of cells whether to proceed or not through its 
growth-and-division cycle. The growth suppressors will determine if a cell should continue 
to proliferate or undergo senescence and apoptotic programs (Burkhart and Sage, 2008).  
Cancer cells usually have defects in RB or TP53 pathways thus, lost the critical 
gatekeeper of cell-cycle and allowing persistent cell proliferation. Evading cell death is the 
third cancer hallmark capability. Cancerous cells develop a variety of strategies to bypass 
apoptosis to succeed in malignancy states and become resistance to therapy. Malignant cells 
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could induce and increase the expression of antiapoptotic regulators such as Bcl-2 and Bcl-
xL or survival signals like Igf1/2. Commonly, cancer cells lost the function of TP53 therefore 
eliminates apoptosis-inducing circuits (Adams and Cory, 2007).  
The next hallmark is enabling replicative immortality of cancer that results in 
generation of macroscopic tumor. Previous researches had demonstrated that the 
immortalized variant cells were capable of maintaining the length of telomeric DNA that 
sufficient to evade triggering of apoptosis or senescence pathways (Blasco, 2005); (Hanahan 
and Weinberg, 2011). Another integral hallmark of cancer is inducing angiogenesis. In order 
to remain alive, tumor cells also need sustenance such as oxygen and nutrients to nourish 
themselves. During tumor progression, “angiogenic switch” is constantly activated thence 
the development of vasculature and angiogenesis persist facilitating neoplastic growth.  
Another hallmark capability is activating invasion and metastasize. Local invasion 
and distant metastasis are the highest pathological states of malignancy. Alterations in shape 
and interaction to extracellular matrix and cell-to-cell adhesion molecules (down-regulation 
of E-cadherin) explained this condition (Berx and Van Roy, 2009). Hanahan and Weinberg 
(2011) later came out with new emerging hallmarks and enabling characteristics as addition 
to the previous hallmarks. The two enabling characteristics are genome instability and 
mutation and tumor-promoting inflammation whilst the two emerging hallmarks are 
reprogramming energy metabolism and evading immune destruction. Figure 2.3 illustrates 
this emerging hallmarks and enabling characteristics. Understanding the hallmarks of cancer 
is important in order to target each of the cancer hallmarks capabalities, enabling 
characteristics  and emerging hallmarks for therapeutics or chemoprevention interventions.  
10 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Common Hallmarks of Uncontrolled Growth. 
(Adapted from Hanahan and Weinberg, 2011). 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Emerging Hallmarks and Enabling Characteristics. 
(Adapted from  Hanahan and Weinberg, 2011). 
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2.2 Cervical Cancer 
2.2.1 Anatomy of cervix 
The uterus also known as womb serves as the pathway for sperm to be deposited, site of 
fertilized ovum implantation, development of fetus during pregnancy and labor. Uterus also 
the source of menstrual flow during reproductive cycle. Anatomical subdivision of the uterus 
classified into fundus, body, and cervix, meanwhile between the body and cervix there is 
isthmus. The cervical canal open into the uterine cavity at the internal os and into the vagina 
at the external os (Tortora and Derrickson, 2009). The anatomy of cervix is shown in Figure 
2.4. 
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Figure 2.4: Overview image of the cervix. 
Adapted from (Tortora and Derrickson, 2009). 
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2.2.2 Types of cervical cancer. 
There are two main types of cervical cancer namely squamous cell 
carcinoma and adenocarcinoma. Most common cervical cancer are adenocarcinomas, which 
account up to 9 out of 10 occurance. Cervical adenocarcinoma advances from the mucus-
producing gland cells of the endocervix whereby it gradually develops pre-cancerous 
modifications that turn into cancer. Several terms to describe these pre-cancerous alterations 
include squamous intraepithelial lesion (SIL), cervical intraepithelial neoplasia (CIN), and 
dysplasia. Early detection by Pap test can treat and prevent these changes and stop cancer 
from developing (American Cancer Society, 2014). Location of cancerous tissue in the 
cervix is shown in Figure 2.5. 
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Figure 2.5: Cancerous tissue in the cervix 
(Adapted from A.D.A.M. Inc., 2013). 
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2.2.3 Staging and symptoms of cervical cancer. 
Cancer of cervix is a disease wherein cancerous cells develop in the tissues of female uterine 
cervix. Initiation of cervical cancer normally arises in cells on the surface and over time, the 
cancerous cells can invade deeper into the cervix and nearby tissues (Sushma et al., 2014).  
The extent of the cancer often expressed in term of its stage. The stage of 
classification is essentially based on clinical examination by means of anatomical extent of 
the disease. It provides information on the size of the tumor, how deep it has grown in the 
tissues and surrounding cervix and how far it has metastasized. In early stage, or widely 
referred as Stage I is classified when the lesion appear to be confined to the organ of origin. 
At Stage II, the tumor has extended locally beyond the site of origin to implicate with 
adjacent structures or organs. Whereas at Stage III, there is more extensive involvement can 
be noticed. And later at Stage IV, notable metastatic spread can be seen. These are the basic 
stages which then further classified into substages, wherein often a reflection of specific 
prognostic factors within a given stage (Benedet et al., 2000). The clinical stages of cervical 
cancer are shown in Table 2.1. 
 The clinical manifestation of early cervical cancer is generally asymptomatic 
whereby the lesion is not visible but detectable through routine cytology screening. 
However, patient with visible lesion usually experience abnormal vaginal bleeding between 
periods, menstrual flows that last longer and heavier, increase vaginal discharge, pelvic pain 
and so forth (Levenback, 2006); (Sushma et al., 2014). 
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Table 2.1: The stages of invasive cervical cancer are as following: (Adapted and modified 
from (Levenback, 2006); (Sushma et al., 2014). 
Stage 0: Carcinoma in situ. 
Stage I: Cervical carcinoma confined to uterus. 
Stage IA1: Measured stromal invasion in horizontal 
spread not more than 3 mm in depth and not wider 
than 7 mm in diameter. 
Stage IA2: Stromal invasion measured greater than 3 
mm but not more than 5 mm in depth and spread not 
more than 7 mm in diameter. 
 
  
Stage IB: Lesion clearly visible confined to the cervix 
or microscopic lesion greater than Stage IA. 
Stage IB1: Size of visible lesion not greater than 4 cm  
Stage IB2: Clinical lesion greater than 4 cm in 
dimension 
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Stage II: Cervical carcinoma invades beyond uterus 
but not to pelvic wall or to the lower third of vagina 
Stage IIA: No obvious parametrial invasion 
Stage IIB: Obvious parametrial invasion but not into 
the pelvic sidewall. 
 
 
Stage III: Cervical carcinoma extends to the pelvic 
wall and/or involves lower third of vagina or causes 
hydronephrosis or nonfunctioning kidney. 
Stage IIIA: Tumor extends to lower third of the 
vagina, but not involves the pelvic wall. 
Stage IIIB: Extension of tumor into pelvic wall or 
causes hydronephrosis or nonfunctioning kidney 
 
 
Stage IVA: Tumor invasion up to mucosa of bladder 
or rectum and/or extends beyond pelvis 
Stage IVB: Distant metastasis 
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2.2.4 Risk factors of cervical cancer 
Statistically, cervical cancer has been reported to be more prevalent among rural women than 
urban women in developing and developed countries. This situation can be linked with 
factors such as low levels of education, unemployment, living in poverty and barriers to 
preventive screening (Wong, 2011). 
Over centuries, it has been well understood that cervical cancer is concomitant of 
sexual activity. The necessary event for the development of cervical cancer is the persistence 
of Human Papilloma Virus (HPV) in the cervix (Moscicki et al., 2012). It is widely accepted 
that HPV is transmitted through sexual contact. Hence, it clarifies the epidemiological 
association concerning cervical cancer incidence and number of sexual partners (Waller et 
al., 2004).  
HPV belongs to the Papillomaviridae family and over 200 genotypes have been 
identified. Examples of high-risk HPV serotypes include 16, 18, 31, 33, 35, 39, 45, 51, 52, 
56, 58, 59, 68, 73, and 82 and should be considered as carcinogenic. The probable high-risk 
types comprise of types 26, 53, and 66 while, HPV classified as low-risk types are 6, 11, 40, 
42, 43, 44, 54, 61, 70, 72, 81, and CP6108 (Munoz et al., 2003). Papillomaviruses are 
simple, non-enveloped and have double stranded deoxy-ribonucleic acid (DNA).  The low-
risk HPV serotypes can cause benign lesion whereas the high-risk HPV serotypes can result 
in malignant lesion. This virus is transmitted via direct contact of mucosa membrane or skin 
and infects the epithelial cells. It requires the presence of micro abrasions or micro trauma in 
the stratified squamous epithelium layer to facilitates penetration into the basal cell layer of 
the cervixdits tropic destination (Haugsdal and Ryan, 2014). The virus will then reproduce 
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within the host cells and after the host cells die, new virus particles will be released and start 
to infect other surrounding cells.  
To add, series of co-factors also involved in the development of cervical cancer. For 
instance, high parity, long-term use of oral contraceptives, immunological factors, smoking 
and other sexually transmitted infections (STIs) have been established as risk cofactors for 
cervical cancer. Some other intervening factors are human immunodeficiency virus, 
Chlamydia trachomatis, herpes simplex simplex virus type 2, and poor dietary (Bosch and 
De Sanjosé, 2002); (Waller et al., 2004). 
 
2.2.5 Screening tools and diagnostic test 
HPV is the only gynecologic cancer that can be prevented by regular screening. Screening 
programs have effectively reduced the burden of cervical cancer in developed countries. 
However, screening and prevention programs face major hurdle like cost constraints, loss to 
follow-up, poor participation, and concerns about sustainability hence becomes a barrier in 
developing countries. Thus, there are efforts to improve the test sensitivity and specificity 
yet affordable (Belinson et al., 2014).  
Pap smear cervical cytology is still considered as primary method for early diagnosis 
of precursor lesions of cervical carcinoma. It is not a diagnostic but a screening test and 
better known as Pap test. It is well understood that no single screening method exist has 
highly specific, highly sensitive, practical and affordable. Hence, other methods have been 
employed to complement the findings of the conventional Pap test such as electron 
microscopy, immunohistochemistry, molecular biology, biomarkers, HPV DNA, polymerase 
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chain reaction (PCR) or by the hybrid capture system (Michalas, 2000); (Dasari et al., 2015). 
Specimens are obtained by scarping cells at the surface of cervix and vagina to be examined. 
 
2.2.6 Vaccination. 
Disease prevention is the principle strategy in dealing with any disease incidence. Well-
established etiologic connection between cervical cancer and HPV infection imposed the 
need of vaccination (Gattoc et al., 2013). Through vaccination, the burden of cervical cancer 
has significantly reduced in developed countries. It is the primary prevention with aim to 
circumvent a disease in its entirety (Haugsdal and Ryan, 2014). The ideal vaccination target 
would be the young adolescents who have the highest risk of HPV infection. It is believed 
that the earlier a person start the sexual contact, the more likely for them to have a persistent 
HPV infection (Al-Naggar et al., 2010). 
The Food and Drug Administration (FDA) has approved numbers of vaccines in the 
markets. The first vaccine introduced by Merck and approved in 2006 is Gardasil vaccine. It 
is a non-live quadrivalent vaccine based on the L1 capsid protein that needs to be 
administered in 3 injections series: on day 0, at 1-2 months, and at 6 months. The second 
vaccine, Cervarix, introduced by GlaxoSmithKline was approved in 2009. This vaccine is 
bivalent which also exploits L1 viral capsid protein as the basis of its efficacy. Cervarix also 
gives protection against anal, vaginal, genital warts, and vulvar cancers. The administration 
is similar to Gardasil schedule. The safety and efficacy evaluation of both HPV vaccines 
established 100% sero-conversion and neither demonstrated any significant or serious 
adverse effects (Gattoc et al., 2013); (Haugsdal and Ryan, 2014).  
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Nevertheless, despite well-established guidelines and recommendations, the 
developing countries like Malaysia and other poor countries faced the greatest barriers to 
implement vaccination program. Due to cost constraint, deprived access to effective 
screening and treatment programs, dissemination of vaccines and social cultural norms make 
vaccination program a challenging effort (Wong, 2011).  
 
2.2.7 Cervical cancer treatment and its side effects. 
To date, the framework for cancer treatment comprises of surgical removal of abnormal 
tissue mass, pro-apoptotic cancer therapeutics such as chemotherapy, radiotherapy, 
immunotherapy, hormone therapy or combination depending on stage of disease and 
histologic type (DeSantis et al., 2014). Patients with early-stage disease (Stage IA1), their 
primary treatment would be surgery or radiation therapy.  Surgery of extrafascial 
hysterectomy, modified radical trachelectomy or hysterectomy with pelvic node dissection is 
recommended (Sushma et al., 2014). While patients with advanced metastatic and recurrent 
disease are treated with surgery followed by radiation therapy (brachytherapy) or 
chemotherapy (cisplatin, bevacizumab, docetaxel, 5-FU,) or combination (DeSantis et al., 
2014); (Sushma et al., 2014). 
Although conventional cancer therapeutics have prolonged the survival, the problem 
is that they often off-target in discriminating normal cells and cancerous cells. Consequently, 
patients faced substantial risk of adverse effects. To exemplify, in radiation therapy “hot 
spots” were observed in normal tissue and sometimes high volumes of radiation in rectum 
and bladder are unavoidable. Besides, patients experiencing acute and chronic toxicity in 
gastro-intestinal system and rectal-lymphatic drainage are common. (Du et al., 2012); 
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(Barillot et al., 2014). Other side effects include infertility in case of hysterectomy and 
menopause symptoms in case of bilateral oophorectomy surgery Moreover, cancer cells are 
now resistant towards chemotherapy thus, makes the conventional therapy ineffective 
(DeSantis et al., 2014). 
 
2.3 Cancer chemoprevention. 
The persistent magnitude of cancer morbidity, the increasing trend in conventional therapy 
failure, the recurrence problem after primary cure, and the deterioration of patient’s quality 
of life indicate that new approaches are critically needed (Kundu et al., 2014). In response, 
there is a rising number in research regarding alternative anticancer therapies and strategies 
in combating this chronic disease. Among the active area of investigation is 
chemoprevention.  
 As was first coined by Sporn in 1976, cancer chemoprevention denotes as 
pharmacological intervention that utilizes natural, synthetic, or biologic chemical agents to 
prevent, suppress, or reverse carcinogenic advancement (Sporn, 1976); (Sporn and Suh, 
2000). This approach addresses cancer disease as primary, secondary, and tertiary cancer 
chemoprevention. The primary chemoprevention tackles cancer initiation by reducing the 
risk of cancer development. Conversely, secondary chemoprevention aims to avert 
malignancy through eradication or induction of stasis in premalignant lesions. Ultimately, 
tertiary chemoprevention purports to inhibit the recurrence of cancer after a successful 
primary cure (Russo, 2007); (Ting et al., 2014). Hence, it is believed that chemoprevention 
agents are not only capable of preventing cancer but are also able to cure it. 
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 Numerous studies have identified numbers of edible plants possessing potential 
chemopreventive compounds widely known as phytochemicals. These compounds are 
classified into two categories: cancer-blocking and cancer-suppressing agents. Cancer-
blocking agents prevent cancer initiation by blocking carcinogens from hitting their targets. 
The mechanisms involved are modifying carcinogen uptake and metabolism, enhancing 
carcinogen detoxification, scavenging reactive oxygen species (ROS) and other oxidative 
species and finally enhancing DNA repair. Whereas, cancer-suppressing agents work by 
inhibiting cancer promotion and progression. These agents interfere with cell signal 
transduction, transcriptional regulation, cycle regulation and  induce apoptosis of pre-
neoplastic cells (Russo, 2007). Understanding the mechanisms of cancer chemoprevention is 
essential for safe application and also permits further expansion of novel treatment regimens 
for cancer patients (Raffoul et al., 2012). 
 Dietary chemoprevention is a potential alternative or additional regimen for cancer 
patients plus it is well-tolerated. Rich phytochemicals consumption in dietary or herbal 
medicines is a convenient mode of administration of chemopreventive phytochemicals and 
moreover it is inexpensive (Gullett et al., 2010); (Ting et al., 2014). Examples of 
chemopreventive agents are curcumin in turmeric, genistein in soy, resveratrol in red grape 
and many more (Shankar et al., 2013). However, in this study chemopreventive agent of 
coconut water (Cocos nucifera) was investigated.  
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2.4 Coconut. 
2.4.1 Botanical description. 
Coconut tree belongs to the family Palmae (Arecaceae), subfamily of Cocoideae, genus 
Cocos L. and species Cocos nucifera L. (USDA, 2015). Botanically, coconut is categorized 
as seed, while people of the tropics consider it as a fruit. The coconut palms are primarily 
classified into two distinct groups that are the tall varieties and the dwarf varieties. The tall 
varieties grow slowly and bear fruits up to 6–10 years after plantation. They are hardy type 
and live up to 80–120 years of ripe age. The coconut fruit takes 11 to 12 months to reach 
maturity. On the other hand, the dwarf varieties are fast growing and bear fruits earlier, at 
age of 4–5 after plantation. They are less hardy compare to tall and require favorable soil 
type and climate conditions to facilitate better yield (DebMandal and Mandal, 2011). 
 Coconut palm usually can be found in the tropic lands. The geographical distribution 
of coconut spread to the region spanning Southeast Asia to the Pacific coast of America and 
across coastal S. Asia, W. Africa, the New World Atlantic, and the Caribbean (Gunn et al., 
2011). In Malaysia, there are 13 varieties of coconut can be found which comprises of: 
1) Malayan Tall 
2) Malayan Red Dwarf (MRD) 
3) Malayan Yellow Dwarf (MYD) 
4) Malayan Green Dwarf (MGD) 
5) West African Tall 
6) Tagnanan Tall 
7) Rennel Tall 
8) Aromatic Dwarf 
